AGM/EGM25 May 2026, 05:21 pm
JB Chemicals Releases FY26 Annual Report
AI Summary
JB Chemicals & Pharmaceuticals Ltd has released its Integrated Annual Report for the fiscal year 2025-26, in compliance with SEBI regulations. The report, along with the notice for the Annual General Meeting scheduled for June 17, 2026, will be sent to the company's shareholders. The annual report highlights the company's legacy, sustainable growth, financial performance, and strategic focus on strengthening its domestic franchise and expanding its international presence. JB Pharma has a presence in 40+ countries with 8 manufacturing facilities.
Key Highlights
- Annual Report for FY26 includes notice of AGM scheduled for June 17, 2026.
- JB Pharma emphasizes sustainable long-term value creation.
- Company has a presence in 40+ countries.
- JB Pharma has 8 manufacturing facilities with global approvals.
- Six JB Pharma brands rank among the top 300 IPM brands.
Price Impact
More from JBCHEPHARM